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We previously found that regression of skin warts in-
duced by the Shope cottontail rabbit papillomavirus in 
New Zealand White rabbits, as well as malignant con-
version of persistent warts, are linked to a restriction 
fragment length polymorphism of the major histo-
compatibility complex class II DRa and DQa genes. 
To find out whether this immunogenetic control could 
be connected with the antigen binding and presenta-
tion function of the a1 domain of class II molecules, we 
have sequenced the exon 2 of the four DRa EcoRI and 
six of the seven DQa Pvull restriction fragment length 
polymorphism alleles identified, and deduced the en-
coded amino acid sequences. We found no amino acid 
polymorphism among DRa alleles, indicating that the 
a1 domain of the DRa chain does not condition wart 
regression or cancer development. In contrast, 27 of 
the 82 amino acids of the DQa1 domain were found 
H uman papillomaviruses (HPV) associated with cu-taneous and anogenital cancers induce intraepithe-lial precursor lesions that may regress, remain un-changed, or progress into invasive carcinoma [1,2]. Cell-mediated immune responses are likely to be 
involved in the regression of warts [3], and there is increasing evi-
dence for HPV-associated cancers being a complication of genetic, 
iatrogenic, or virus-induced immunosuppression [4-11]. Genetic 
and immunologic factors are likely to playa role in the development 
of HPV-associated skin cancers in patients suffering from epider-
modysplasia verruciformis [1] . 
Evidence has been obtained in humans and in rabbits that suggests 
an immunogenetic control of regression or progression to cancer of 
PV-associated lesions. A higher relative risk of developing a cancer 
of the uterine cervix has been found associated with human leuko-
cyte antigen (HLA) DQW3 and a decreased risk with HLA-DR6 
antigen [12,13], but subsequent studies found a weaker linkage 
[14,15] or none [16,17]. More recently, specific DR-DQ haplotypes 
were found significantly associated with either susceptibility or re-
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variable, defining five amino acid sequence alleles. 
The restriction fragment length polymorphism allele 
linked to regression and another allele not linked to 
regression share the same a1 domain, indicating that 
wart regression is rather conditioned by a closely 
linked gene. The most divergent DQa1 allele, how-
ever, was that associated with a higher risk of cancer. 
Alignment of rabbit and human DQa exon 2 alleles 
disclosed that amino acid charge variations occur at 
positions assumed to be important for peptide binding 
in humans. By modulating the affinity for tumor-spe-
cific antigenic peptides, such transitions could affect 
immune surveillance and, thus, condition the risk for 
progression to carcinoma of papillomavirus-asso-
ciated lesions. Key words: Viral carcinogenesis/tumor 
progression/immune surveillance/major histocompatibility 
complex.] Invest Dermatol103:376-380, 1994 
sistance to cervical carcinoma and these associations were HPV type 
specific [18]' Immunosuppressed patients with HLA-A11 have been 
reported to be protected against the development of skin carcinomas 
[19] and those with HLA-DR7 at increased risk [20]. However, 
except for patients with epidermodysplasia verruciformis, the asso-
ciation of skin carcinoma with HPV is far from being proved [1,21]. 
We have previously found that the regression and malignant trans-
formation of persistent skin warts induced by the Shope cottontail 
rabbit papillomavirus (CRPV) in New Zealand White domestic 
rabbits are linked to specific alleles of the major histocompatibility 
complex (MHC) class II rabbit leukocyte antigen (RLA)-DRa and 
DQa genes [22], as defined by a restriction fragment length poly-
morphism (RFLP) [23]. Of the four DRa alleles (RLA-DRaA-D) 
and the seven DQa alleles (RLA-OQaA-G) identified, two alleles 
in linkage disequilibrium (RLA-DRaB and OQaE) were found to 
be strongly linked to regression, whereas RLA-OQaG was found 
associated with a 4.5-times higher risk of wart malignant conver-
sion in the year following infection [22] . 
Class II antigens consist of an a chain and a fJ chain, whose 
N-terminal a1 and fJ1 domains are involved in the binding of for-
eign antigenic peptides and their presentation to T lymphocytes 
[24]. In the proposed model for class II molecules, some amino acid 
P?sit.ions have been assumed to be crucial for antigenic peptide 
bmdmg, and several of them are polymorphic [25,26]. A polymor-
phism of the a1 domain of ORa and OQa chains could thus condi-
tion the affinity of class II molecules for PV - or cell-encoded tu-
moral antigens expressed at different stages of tumor progression. 
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Figure 1. Simplified maps ofRLA-DRa (a,c,d) and DQa (b) genes. 
The three aligned maps of the ORa gene were either deduced from ORa 
nucleotide sequence established by Laverriere e/ al [27] (a) or compiled from 
the restriction maps of two ORa alleles cloned from a heterozygous rabbit 
previously described by Sittisombut et al [45,51] (c,d). The 5' end of the clone 
represented in d is indicated by an arrowhead. The DQa map (b) has been 
deduced from DQa nucleotide sequence determined by LeGuern et al [28]. 
Numbers indicate exons. Untranslated sequences are in black. A degenerated 
Pvull site found in DQa exon 5 is indicated by a star. The positions of the 
2-kb DRa probe [27] (a) and 2.2-kb DQa probe [28] (b) described in Materi-
als and Methods are indicated. Comparison of restriction maps of the ORa 
region (a,c,d) discloses polymorphic EcoRI sites in introns 1 and 2 and 
downstream coding sequences. Insertion/deletion events downstream ORa 
gene are likely to account for the shift of the segment indicated by a dotted 
line. R, EcoRI; Pv, PvuIl; H, HmdIII; H, HamHI; K, KpnI; P, Pst!' 
This would result in a variable efficacy of the immunologic control 
of PV -associated neoplasias. To find out whether such a polymor-
phism could account for t~e differences in .~art evolution observed 
in rabbits, we have determmed the nucleotldlc sequence of the exon 
2 encoding the al domain of the different DRa and DQa mole-
cules . We have aligned the highly polymorphic RLA-DQa alleles 
with the human HLA-DQa alleles to identify the amino acid posi-
tions corresponding to those assumed to be important for antigen 
binding in people. 
MATERIALS AND METHODS 
Rabbits and CRPV Infection Sixteen New Zealand White rabbits were 
analyzed. Thirteen rabbits originated from CEGAV, Passais la Conception, 
France, one from the Institut National de la Recherche Agronomique, 
JOuy en Josas, France and two from Hazelton Research Animals, Denver, 
PA. Fourteen rabbits were infected with CRPV as described [22]. In these 
experimental conditions, skin warts develop after 3 - 5 weeks. Complete 
regression occurs in early regressors 1 - 6 weeks after wart outgrowth (about 
55% of the rabbits) or after 8-14 weeks in late regressors (about 15% of the 
rabbits). Persistor rabbits (about 30%) keep their warts for over 16 weeks and 
about half of them will develop carcinomas in less than 1 year after infection 
[22]. 
RFLP Typing The ORa and DQa genotypes of rabbits were determined 
by an EcoRI and PvuIl RFLP, as described previously [22,23]' The probes 
used in blot hybridization experiments were a 2 kb HindIIl - Stu I DNA 
fragment comprising the exon 3, 4 and 5 of the ORa gene [27] and a 2.2-kb 
HindIII DNA fragment encompassing the exon 2, 3, 4, and 5 of the DQa 
gene [28] (Fig 1). 
PCR Amplification of DR a and DQa exon 2. The second exon of the 
EcoRI-DRa alleles and PvuIl-DQa alleles previously identified in rabbit 
[22] was amplified bY'polymerase chain reaction (PCR) . The 5' and 3' 
primers for PCR amplIficatIOn of ORa exon 2,5'TTCTGCATCTCCC-
TCTGCTG3'/5'TAATGTAACACACAGGACA3', and of DQa exon 
2, 5'CAGAGTCTTTGCCAGAGATGAAACCCA3' /5'GTTCAGT AA-
TACTGCAAGAAGA3', were chosen in the intronic sequences flal1king 
the second exon of the ORa [27] and DQa [28] genes. PCR experiments 
were performed in a PCR processor (Hybaid Ltd., UK) as described by Saiki 
e/ al [29]. Genomic DNA (1 J.lg) prepared from white blood cells [22] was 
amplified for 30 cycles of denaturation (94 °C, 30 seconds), annealing 
(52°C, 1 min), and synthesis (72°C, 2 min). Cycles were completed by a 
final extension of7 min at 72°C. The 100-J.lI reaction mixture contained 25 
mM KCI, 20 mM Tris, pH 8.3, 1.5 mM MgCI2' 100 J.lg bovine serum 
albumin, 200 J.lM dNTP, 2 U Thermus aquaticus DNA polymerase (Amer-
sham International, UK), and 50 pmoles of oligonucleotide primers. 
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DNA Sequencing The amplified exon 2 fragments were cloned after 
insertion by blunt end ligation at a SmaI site into pGEM4 vector (Promega 
Corp., Madison, WI) and sequenced on both strands by the dideoxynuclco-
tide primer extension method, using T7 and SP6 promotor sequencing 
primers (Promega Corp.) (Table I). All methods were as described [30] . The 
nucleotide sequence data on DQa exon 2 reported here have been deposited 
in EMBL data bases under accession numbers X71613 (o.cuniculus RLA-
DQa gene Pvull RFLP allele A), X71614 (o.cuniculus RLA-DQa gene 
Pvull RFLP allele C), X71615 (o.cuniculus RLA-DQa gene Pvull RFLP 
allele H, E), X71616 (o.cuniculus RLA-DQa gene PvuII RFLP allele D) , 
and X71617 (o.cuniculus RLA-DQa gene Pvull RFLP a.llele G). 
Analysis of Sequence Similarities A dendrogram was constructed from 
the live deduced amino acid sequences of the al domain of RLA-DQa 
chain, on the basis of similarity scores generated by the fast comparison of the 
sequences by the unweighted pair group maximum average (UPGMA) 
method, using the Clustal V package [31]. 
RESULTS 
Characteristics of Rabbits The 16 N ew Zealand White rabbits 
included in the study were selected on the basis of their DRa and 
DQa genotypes (22) and their response to CRPV infection (Table 
I). DRa and DQa alleles were determined according to an EcoRI 
and Pvull RFLP, respectively [22,23) . Homozygous rabbits were 
found for each of the DRaA-D alleles and for four (DQaB,C,E,G) 
of the seven DQa alleles identified (22). The DQaA and D alleles 
were rarely found in our series and only in heterozygous rabbits. 
DQaF allele, encountered only once, was not sequenced. Of the 16 
rabbits, 14 had been infected with CRPV particles. Seven rabbits 
regressed within 1 -6 weeks (early regressors) and two were late 
regressors. Five rabbits were persistors, two with carcinomas 
(Table I). 
Nucleotide Sequence Divergence Among RLA-DRa and 
-DQa exon 2 We amplified and cloned the second exon of the 
four EcoRI RFLP DRa alleles and of six Pvull RFLP DQa alleles 
by PCR, using genomic DNA preparations and oligonucleotide 
primers chosen in intronic sequences fl anking exon 2. Several 
clones, obtained from 1 - 3 PCR experiments and from 1- 5 rabbits, 
were sequenced for each allele, as indicated in Table I. On the 
whole 83 clones were sequenced, including 25 clones from 5 rabbits 
from two rabbitries for DRaB, the allele strongly linked to regres-
sion, and 15 clones from three rabbits from two rabbitries for 
DQaG, the allele associated to a higher risk of cancer development. 
The exon 2 sequence of RLA-DRaD was found to correspond to 
the published RLA-DRa sequence established from a BJ rabbit (27) . 
Four variable nucleotide positions out of 246 were identified in the 
other alleles, corresponding to codons 40 (GTC -+ GTT), 58 
(CTG -+ TTG), 76 (AAT -+ AAC), and 79 (CCA -+ CCG). The 
EcoRI site located in exon 2 (nt 3048) (27) (Fig 1) is conserved in all 
alleles sequenced. When compared to the published sequence, 
RLA-DRaA showed one mutation (codon 79); RLA-DRaB, three 
mutations (codons 58, 76, and 79); and RLA-DRaC, two mutations 
(codons 40 and 79). None of these variations results in an1ino acid 
changes. 
The exon 2 nucleotide sequences of RLA-DQaB, not found 
linked to regression [22], and of DQaE, the allele in linkage dis-
equilibrium with DRaB [22], were found to be identicaJ and to 
correspond to the published RLA-DQa sequence established from a 
BJ rabbit [28]. The three first nucleotides of the eXOJ1 2 belong to a 
PvuII site that is conserved in all alleles (Fig 2) . Variations at 38 
nucleotide positions out of 246 were identified in the four other 
alleles. This corresponds to 31 of 82 codons (Fig 2) and results in 27 
amino acid changes (32%) (Fig 3) . Thirteen, 7, 18, and 20 nucleo-
tide substitutions, corresponding to 10, 5, 11, and 18 amino acid 
changes, were found for DQaA, C, D, and G, as compared to 
DQaB and E. If one excepts DQaB and E, RFLP alleles correspond 
each to a DNA sequence variant. 
A dendrogram constmcted by aligning the deduced amino acid 
sequences of the al domains of RLA-DQa chains shows that the 
most divergent allele is DQaG (data not shown). Twelve changes 
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Table I. Nucleotide Sequence Analysis of the Polymorphism of the Exon 2 ofRLA-DRa and -DQa Alleles 
RFLP Genotypes' 
Number of Sequenced C lones 
Rabbit' Wart Evolutionb DRO' DQO' (Number of PCR Experiments) 
1 Early regressor AA AE 2 DRaA (1) 
2 Early regressor BB EE 5 DRaB (1) 
3 Early regressor BB EE 5 DRaB (1) 
4 Early regressor BB EE 5 DRaB (1) 
5 Early regressor BB EE 5 D RaB (1) 
6 Early regressor BB EE 5 DRaB (1) 
7 Uninfected CC BC 4 DRO'C (1) 
8 Carcinoma CC GG 4 DRaC (1) 
9 Late regressor DD BC 2 DRaD (1) 
10 Persistor AC AG 5 DQaG (3), 4DQaA (3) 
11 Late regressor DD BB 5 DQaB (2) 
12 Persistor CD BB 5 DQaB (2) 
13 Persistor CC CC 4 DQO'C (1) 
14 Carcinoma CC CD 3 DQaC (3) , 4DQaD (3 ) 
15 Early regressor AC EE 6 DQaE (1) 
16 Uninfected BC EG 6 DQaG (2) 
8 Carcinoma CC GG 4 DQO'G (2) 
• All rabbits were from the same origin. except for rabbit 16 from another French rabbitry and rabbits 5 and 6 from the United States . 
I As described in Material alld Metllods. 
, Alleles were determined as described previously [22J. 
are specific to this allele. The second most divergent allele DQaD 
shows eight amino acid substitutions unique to this allele. Four 
substitutions specific for DQaA were identified but none of the 
changes were specific for DQaC (Fig 3). 
Alignment of the Amino Acid Sequences of RLA and HLA 
DQa Rabbit DQa sequences were aligned with those of the six 
major human DQa (HLA-DQAl) alleles [32] (Fig 3). The hyper-
vari able regions ofRLA-DQa gene are clustered between positions 
3 - 1"1, 40 - 50, and 63 - 72, which correspond to areas of significant 
polymorphism in humans [241. According to the model proposed 
for class II molecules [25,26], a number of positions are putative 
antigen-binding sites (Fig 3). The radical changes [33] affecting 
such positions in rabbit exon 2 sequences are found at positions 29 
(GIn --+ Glu), 45 (Glu --+ Met) , 48 (Arg --+ Glu) for DQaD, 35 
(Asp --+ Gly) for DQaG, and 74 (Arg --+ Asp) for DQaA (Fig 3). 
Codon No 10 
RLA-DQD.B, E CAG.J..cT GAG CAC STT GGC TCC TAT GGC ATA MC GTC 
RLA-DQo.A G- - -CG 
RLA-DQD.C G-- -CG ---
RLA-DQo.D A--
RLA-DQD.G --- G-- -CG --- 1'--
Codon No 30 
RLA-DQD.B, E GAT GAG CAG TTC 1'1,1' GTA GAC CTG GAT MG MG GAG 
RLA-DQo.A 
RLA-DQD.C 
RLA-DQo.D - - A G- - --G 
RLA-DQD.G -G-
Codon No 60 
RLA-DQD.B,E CAG GGT GCA CTG GGA MC IITA GCC ACA GCA AM TIIC 
RLA-DQaA -G-
RLA-DQD.C 
RLA-DQo.D AT-
RLA-DQD.G A-- 1'-- -G- -G- CT-
TAC 
-G-
ACT 
Interestingly, all these changes affect the amino acid charge. In 
humans, four of the five corresponding positions, 34, 40, 50, and 
53, show also charge variations (Fig 3) . 
DISCUSSION 
Transformation into invasive carcinoma of lesions induced by on-
cogenic papillomaviruses is a multistep process controll ed by the 
capacity of the host to achieve regression of non-invasive precursor 
lesions [1,2]. Regression is likely to involve cell-mediated immune 
responses [1 ,3,34,35], most probably directed against the viral E6 
and E7 oncoproteins [36,37]' Strikingly, only a proportion of rabbits 
[22] or women [38,39] with persistent precursor lesions will de-
velop cancer. Either some events required for tumor progression do 
not occur [1,2] or immune surveillance efficiently eliminates 
emerging malignant ce ll s [40]. In addi tion to the E6 and E7 viral 
20 
CAG TCT TAT GGT CCC TCT GGC CAG TAC ACC CAT GM TTl' GAT GGA 
-11-
-1'-
~o 50 
ATC TGG IIGG CTT TCT GAG 1'1'1' AGC IIG;, 1'1'1' GCA AGT TTT GAT CCA 
C-- 1'.--
C-- 11- -
G-- --C --G C-- AT - C-- GA- 1'.--
C-- -A-
70 80 82 
MC TTG GAC ATC ATA 111'1' l\Al". CGC TTC AAC TCT ACT GCT GCT GTC ."-"'T 
C-- C-G GA- A--
--G --C 
--G --C 
-C- G-- --G --G A--
Figure 2. Nucleotide sequences of the exon 2 of rabbit MHC class n DQO' alleles. Numbcrin g starts at the first codon aftcr the splice site indicated by an 
arroUi [28]. Dashes, identity with the uppermost sequence. The Pvull site encompassing the 5' end of the second cxon is indicated by a solid /ille. 
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Figure 3. Alignment of the amino acid sequences of the at domain ofRLA-DQa and HLA-DQa chains. Amino acids are noted by standard one 
letter symbols. Dashes, amino acids identical to the uppermost sequence. Amino acid numbering for RLA and HLA a.lleles are indicated at the top and the 
bottom of the sequences, respectively. Blatlk, sequence was not determined, except for position 55 in several HLA-DQA 1 alleles, where a space was included 
for alignment purposes. Sequences ofHLA-DQAl alleles were taken from Horn et al [32] and Marsh and Bodmer [52]. Stars at the bottom line, the positions 
assumed to be important for antigen binding, according to the model proposed for human class II molecules [25]. Slars below RLA-DQa sequences, putative 
antigen-binding sites affected by an amino acid charge variation among RLA-DQa alleles. 
oncoproteins, which are expressed at all stages of tumor progression 
[1,2,36,37] cellular proteins mutated or upregulated during tumor 
progression may be recognized also as tumor antigens [41]. 
A polymorphism of the genes involved in the presentation of 
antigenic peptides, such as genes encoding MHC class I [42] and II 
[24] molecules, could be responsible for the variability of the host 
response. We have previously found that the regression of warts and 
the malignant conversion of persistent warts in New Zealand 
White rabbits are linked to a RFLP of DRa and DQa genes [22]. 
Our aim was to determ.ine whether a polymorphism of the exon 2 of 
RLA-DRa and -DQa genes, which encodes the a1 domain in-
volved in the binding and presentation of antigenic peptides, could 
account for the variable capacity to reject warts or to control the 
emergence of malignant cells. We find that the RFLP alleles corre-
spond to specific exon 2 nucleotidic sequence variants, except for 
twO DQa RFLP alleles which share the same sequence. This raises 
the question of the relationship between RFLP alleles and exon 2 
sequence alleles. Based on the available restriction maps of the 
RLA-DRa region and -DQa gene (Fig 1) and on our data showing 
the conservation of the EcoRI site in DRa exon 2 and the PvuII site 
encompassing the 5' end of DQa exon 2, it is most likely that the 
DRa and DQa RFLP involves EcoRI and Pvull polymorphic sites 
located in non coding sequences. We find no evidence for exon 2 
sequence variations for the same RFLP allele sequenced from sev-
eral rabbits: 5 for DRaB, 3 for DQaG, 2 for DRaC, DQaB, and 
DQaC. This supports a correspondence between exon 2 sequence 
alleles and RFLP alleles within our New Zealand White rabbit 
strain. 
We previously found a strong linkage between wart regression 
and DRa and DQa RFLP alleles in linkage disequilibrium (DRaB 
and DQaE) [22]. We disclose here only a minor exon 2 polymor-
phism of RLA-DRa gene, which does not result in a polymorphic 
a1 domain. In contrast, we observe a great polymorphism of DQa 
exon 2. However, of the two DQa alleles encoding the same a1 
domain, only one of them, RLA-DQaE, has been found associated 
with regression [22]. This sequence allele has been characterized 
first in inbred BJ rabbits [27,28] , in which CRPV-induced warts do 
not regress [43] . Thus, the polymorphism of DR a and DQa exon 2 
does not seem to be involved directly in the variable capacity to 
reject warts. It cannot be excluded, however, that the linkage ob-
served could involve some functions of class II molecules encoded 
by exon 3, such as interactions with CD4 molecules or formation of 
MHC molecule dimers [44] . Because class II molecules consist of an 
a chain and p chain [24], it could be that the genes directly involved 
in the variability of wart evolution are the closely linked polymor-
phic genes encoding the p chains [45]. Genes located in the vicinity 
of class II genes, such as those involved in the processing or transport 
of antigenic peptides delivered to class I molecules [46] , could be 
good candidates also. Worth noting, our recent RFLP analysis of 
RLA-DRap and RLA-DQap genes in a series of infected rabbits 
resulted in the identification of a DR-DQ haplotype linked to re-
gression, which includes DRaB and DQaE, and an haplotype asso-
ciated to a higher risk of cancer, which comprises DRaC and 
DQaG (R. Han, F. Breitburd, P. Marche, and G. Orth, unpublished 
results). No sequence data are available yet on RLA-DRP and DQP 
genes. 
The same hypotheses could account also for the association of 
RLA-DQaG with a higher risk of cancer. However, the G allele 
being the most divergent among DQa alleles, it could well be 
that the polymorphism of the al domain of DQa molecules is 
directly cOImected with the variable capacity of rabbits to control 
the emergence of malign31lt cells from persistent warts. A lower 
efficiency in the binding and presentation of 3l1tigenic peptides 
specific for tumor progression could account for the higher risk 
of cancer associated with DQaG. The RLA-DQaG allele shows 
a unique radical amino acid change shared by some human DQa 
alleles at one of the putative 3l1tigen-binding sites of class II mole-
cules [25] (Fig 3). This change is from a negatively charged 
amino acid to a glycine residue at position 35 and at the cor-
responding position 40 in HLA-DQA1*0401, DQAl*0501, and 
DQA1 *0601. In Caucasians, DQA1 *0501 is in linkage disequilib-
rium with DQB1 *0301 [47,48]' which has been reported to be at 
increased frequency among Caucasian cervical carcinoma patients 
[13]. This polymorphic site corresponds to position 45 in class I 
molecules [25], constitutive of a most important peptide-binding 
pocket [49,50]. Three other putative antigen-binding sites, also 
polymorphic in HLA-DQA1 alleles (Fig 3). show amino acid 
charge variations in the RLA-DQaD allele. We have found this 
allele only four times in 123 infected rabbits, but each time in 
persistors, two of them with carcinomas ([22]; our unpublished 
results). 
In conclusion, our data do not support that the variable capacity to 
reject warts is directly linked to the polymorphism of the exon 2 of 
RLA-DRa and -DQa genes but rather point to the involvement of 
some closely linked polymorphic gene(s). They do not exclude, 
however, that allele-specific variations of DQ molecules may con-
dition the efficiency of the immunologic eradication of emerging 
cancer cells by affecting the binding or presentation of antigenic 
peptides specific of tumor progression. The recent evidence for 
HPV type-specific associations of HLA DR-DQ haplotypes with 
susceptibility or resistance to cervicaJ cancer among Hispanic 
women [18] together with our observations in the rabbit are of 
major relevance for understanding the biology of infection by geni-
tal and cutaneous oncogenic HPV types. 
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